1-2 of 2
Marie Ghosn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Hyper-CVAD Plus Ofatumumab As Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia: Updated Results of a Phase II Trial

Abhishek Maiti, MBBS, Hagop M. Kantarjian, MD, Farhad Ravandi, MBBS, Maria Khouri, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Rebecca Garris, Msc, Jorge E. Cortes, MD, Nicholas J Short, MD, Nitin Jain, MD, Prithviraj Bose, MD, Srdan Verstovsek, MD PhD, Marina Konopleva, MD PhD, Koji Sasaki, MD, Ghayas C. Issa, MD, Marie Ghosn, Heather M Schroeder, Tapan Kadia, MD, Naval Daver, MD, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3876.
https://doi.org/10.1182/blood.V130.Suppl_1.3876.3876
Published: 2017
Journal Articles

Omacetaxine Mepesuccinate for Patients with Higher-Risk MDS and CMML after Failure of Hypomethylating Agents: A Phase II Trial

Nicholas J Short, MD, Guillermo Garcia-Manero, MD, Kiran Naqvi, MDMPH, Steven Kornblau, MD, Koichi Takahashi, MD, Guillermo Montalban-Bravo, MD, Rita Khouri, Michael Andreeff, MD PhD, Marina Konopleva, MD PhD, Courtney D. DiNardo, MDMSc, Yesid Alvarado, MD, Marie Ghosn, Zeev Estrov, MD, Prithviraj Bose, MD, Rubiul Islam, Xiao Dong, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2967.
https://doi.org/10.1182/blood.V130.Suppl_1.2967.2967
Published: 2017